Psychedelic Spotlight

While scientific literature on athleticism and psychedelics is still in its embryonic stages, there’s a deep well of anecdotal evidence suggesting that psychedelics could bring athletes to new peaks of performance.

This week in psychedelic business news: Cybin inhales; atai Life Sciences expands; DEA grants new psilocybin license; and FDA backs ketamine.

The resolution, however, does not authorize the commercial sale of entheogenic plants and fungi, nor cultivation for large-scale distribution.

In this chat, he discusses some of the challenges involved in moving virtual events to an in-person conference (during a pandemic), who and what to expect at the event, and why Wonderland Miami is not just any other conference, but a one-of-a-kind experience.

A Johns Hopkins Medicine professor says "it was only a matter of time," while lead researcher calls the historic grant "monumental" for the psychedelics movement.

Focus on these five key nutrients to better support your body and increase the likelihood of enjoying your psychedelic experience.

In our conversation with Joseph, we chat a bit about some critical topics such as how psychedelics can allow us to understand the Indigenous philosophy of interrelatedness between one another and our ecosystems, the importance of considering sacred reciprocity to Indigenous peoples and their land, and how Chacruna's Indigenous Reciprocity Initiative is making it simple for companies to give back to the societies who have cultivated psychedelic medicine.

"Let's spend the time researching, looking into how these plant medicines were made to help us," the two-time Grammy winner says during end-of-life psychedelic conference.

Our resident psychedelic investor explains why psychedelic stocks are plummeting, and why patience can pay off big time.

The leader of the Conservative Party in the United Kingdom tells a Member of Parliament "we will consider the Advisory Council on the Misuse of Drugs' recent advice on reducing barriers to research with controlled drugs."

CEO James Lanthier compares psychedelic medicines to aspirin, and explains why the company's lead candidate may be better than psilocybin.

There is increasing scientific evidence that a variety of psychedelics can be used to treat a number of the risk factors linked to suicide, in addition to reducing suicidality.